Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 1;107-B(5):522-528.
doi: 10.1302/0301-620X.107B5.BJJ-2024-1007.R1.

Labelling patients as allergic to beta-lactam antibiotics is associated with periprosthetic joint infection up to five years following knee arthroplasty

Valerie Chiang  1 , Hugo W F Mak  2 , Amy Cheung  3 , Kwong-Yuen Chiu  3 , Henry Fu  3 , Michelle H Luk  3 , Man H Cheung  3 , Philip H Li  2
Affiliations

Labelling patients as allergic to beta-lactam antibiotics is associated with periprosthetic joint infection up to five years following knee arthroplasty

Valerie Chiang et al. Bone Joint J. .

Erratum in

  • Erratum.
    Chiang V, Mak HWF, Cheung A, Chiu KY, Fu H, Luk MH, Cheung MH, Li PH. Chiang V, et al. Bone Joint J. 2025 Jun 1;107-B(6):663. doi: 10.1302/0301-620X.107B6.BJJ-2025-00056. Bone Joint J. 2025. PMID: 40449938 No abstract available.

Abstract

Aims: Periprosthetic joint infections (PJIs) represent a significant complication of total knee arthroplasty (TKAs). However, the influence of drug or beta-lactam (BL) antibiotic allergy labelling of patients on PJI remains largely unknown. In this study, we examine the association between patients labelled with a BL allergy and the occurrence of PJI among patients undergoing TKA. We also assess the prevalence of incorrect patient labelling and explore the feasibility of a multidisciplinary drug allergy testing initiative to detect mislabelling.

Methods: Longitudinal data from all patients who underwent TKA between January 1993 and December 2021 were analyzed. We investigated the association between different risk factors and PJI, with particular focus on patients labelled as having an antibiotic drug allergy. The outcomes of patients with and without a labelled BL allergy were compared. Additionally, patients labelled as having a BL allergy and who had undergone or were scheduled for TKA were prospectively investigated by formal allergy assessment.

Results: Out of 4,730 TKAs, the overall incidence of PJI was 1.0% (47/4,730). Patients labelled as having a BL allergy had a higher incidence of PJI within the first five years post-TKA compared to those without (3.0% (5/165) vs 0.7% (34/4,565); p = 0.001). The presence of a BL allergy label was identified as an independent risk factor for PJI (hazard ratio 4.86 (95% CI 2.05 to 11.53); p < 0.001). Following negative drug provocation testing, the majority of patients (95% (21/22)) evaluated with BL allergy labels were successfully delabelled.

Conclusion: In this longitudinal study, patients labelled as having a BL allergy were associated with having increased risk of PJI following TKA, particularly within the first five years. Given the high rate of patients being mislabelled, we recommend that patients labelled as having a BL allergy should be prioritized for formal allergy assessment and evaluation. Further studies on the impact of preoperative antibiotic allergy delabelling initiatives should be encouraged.

PubMed Disclaimer

Conflict of interest statement

All authors reported no conflicts of interest in relation to this paper.

References

    1. Patel R . Periprosthetic joint infection . N Engl J Med . 2023 ; 388 ( 3 ): 251 – 262 . 10.1056/NEJMra2203477 36652356
    1. Tande AJ , Patel R . Prosthetic joint infection . Clin Microbiol Rev . 2014 ; 27 ( 2 ): 302 – 345 . 10.1128/CMR.00111-13 24696437
    1. Kurtz SM , Ong KL , Lau E , Bozic KJ , Berry D , Parvizi J . Prosthetic joint infection risk after TKA in the medicare population . Clin Orthop Relat Res . 2010 ; 468 ( 1 ): 52 – 56 . 10.1007/s11999-009-1013-5 19669386
    1. Tsikopoulos K , Meroni G . Periprosthetic joint infection diagnosis: a narrative review . Antibiotics (Basel) . 2023 ; 12 ( 10 ): 1485 . 10.3390/antibiotics12101485 37887186
    1. Reinhard J , Lang S , Walter N , et al. In-hospital mortality of patients with periprosthetic joint infection . Bone Jt Open . 2024 ; 5 ( 4 ): 367 – 373 . 10.1302/2633-1462.54.BJO-2023-0162.R1 38663864